The role of ADAM17 in tumorigenesis and progression of breast cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of ADAM17 in tumorigenesis and progression of breast cancer
Authors
Keywords
Breast cancer, A disintegrin and metalloproteinase, ADAM17, Mechanisms, Marker
Journal
TUMOR BIOLOGY
Volume 37, Issue 12, Pages 15359-15370
Publisher
Springer Nature
Online
2016-09-22
DOI
10.1007/s13277-016-5418-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Review on Novel Breast Cancer Therapies: Photodynamic Therapy and Plant Derived Agent Induced Cell Death Mechanisms
- (2016) Blassan Plackal Adimuriyil George et al. Anti-Cancer Agents in Medicinal Chemistry
- Adam17, a Target of Mir-326, Promotes Emt-Induced Cells Invasion in Lung Adenocarcinoma
- (2015) Ming Cai et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy
- (2015) D. Aydin et al. Clinical & Translational Oncology
- MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells
- (2015) Jing Wu et al. EXPERIMENTAL CELL RESEARCH
- Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?
- (2015) Maurizio Romano et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hypoxia-induced fibroblast growth factor 11 stimulates capillary-like endothelial tube formation
- (2015) JIMIN YANG et al. ONCOLOGY REPORTS
- ADAM10 and ADAM17: New Players in Trastuzumab Resistance
- (2015) Michael J. Duffy et al. Oncotarget
- HER2-positive advanced breast cancer: optimizing patient outcomes and opportunities for drug development
- (2014) J C Singh et al. BRITISH JOURNAL OF CANCER
- Deciphering the Role of the ADAM17-Dependent Secretome in Cell Signaling
- (2014) Rebeca Kawahara et al. JOURNAL OF PROTEOME RESEARCH
- ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma
- (2014) Qin Xu et al. TUMOR BIOLOGY
- Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-κB signaling
- (2013) Stephen L. Rego et al. ANGIOGENESIS
- Twist1 Induces CCL2 and Recruits Macrophages to Promote Angiogenesis
- (2013) J. M. Low-Marchelli et al. CANCER RESEARCH
- ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway
- (2013) Xiang-jun Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- ADAM-17: a novel therapeutic target for triple negative breast cancer
- (2012) P. M. McGowan et al. ANNALS OF ONCOLOGY
- A novel bispecific single-chain antibody for ADAM17 and CD3 induces T-cell-mediated lysis of prostate cancer cells
- (2012) Kosuke Yamamoto et al. BIOCHEMICAL JOURNAL
- Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo
- (2012) Frances M. Richards et al. PLoS One
- Increased expression of ADAM12 and ADAM17 genes in laser-capture microdissected breast cancers and correlations with clinical and pathological characteristics
- (2011) Diana Narita et al. ACTA HISTOCHEMICA
- Activation of epidermal growth factor receptor signaling by the prostaglandin E2 receptor EP4 pathway during gastric tumorigenesis
- (2011) Hiroko Oshima et al. CANCER SCIENCE
- ADAM17 promotes glioma cell malignant phenotype
- (2011) Xuguang Zheng et al. MOLECULAR CARCINOGENESIS
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- Inflammatory Skin and Bowel Disease Linked toADAM17Deletion
- (2011) Diana C. Blaydon et al. NEW ENGLAND JOURNAL OF MEDICINE
- A KrasG12D-driven genetic mouse model of pancreatic cancer requires glypican-1 for efficient proliferation and angiogenesis
- (2011) C A Whipple et al. ONCOGENE
- M-CSF Induces Monocyte Survival by Activating NF-κB p65 Phosphorylation at Ser276 via Protein Kinase C
- (2011) Yijie Wang et al. PLoS One
- ADAM17: a molecular switch to control inflammation and tissue regeneration
- (2011) Jürgen Scheller et al. TRENDS IN IMMUNOLOGY
- Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17
- (2011) Thorsten Maretzky et al. Nature Communications
- Prognostic Factors Affecting the Outcome of Salvage Radiotherapy for Isolated Locoregional Recurrence After Mastectomy
- (2010) Kyubo Kim et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- ADAMs and protein disulfide isomerase: the key to regulated cell-surface protein ectodomain shedding?: Figure 1
- (2010) Rosemary Bass et al. BIOCHEMICAL JOURNAL
- ADAM17: The new face of breast cancer-promoting metalloprotease activity
- (2010) Kristine Glunde et al. CANCER BIOLOGY & THERAPY
- ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation
- (2010) Xuguang Zheng et al. CANCER BIOLOGY & THERAPY
- The “A Disintegrin And Metalloproteases” ADAM10 and ADAM17: Novel drug targets with therapeutic potential?
- (2010) Paul Saftig et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
- (2010) Athena Chalaris et al. JOURNAL OF EXPERIMENTAL MEDICINE
- NF-κB as a central regulator of macrophage function in tumors
- (2010) Subhra K. Biswas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Improved Estimates of Cancer-Specific Survival Rates From Population-Based Data
- (2010) Nadia Howlader et al. JNCI-Journal of the National Cancer Institute
- HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer
- (2010) Merel Gijsen et al. PLOS BIOLOGY
- Regulation of macrophage function in tumors: the multifaceted role of NF- B
- (2009) T. Hagemann et al. BLOOD
- Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941
- (2009) Teemu T. Junttila et al. CANCER CELL
- ADAM17 as a Therapeutic Target in Multiple Diseases
- (2009) Joaquin Arribas et al. CURRENT PHARMACEUTICAL DESIGN
- Expression of Tumor Necrosis Factor α Converting Enzyme in Endocrine Cancers
- (2008) Tove Kirkegaard et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- ADAM-17 predicts adverse outcome in patients with breast cancer
- (2008) P. M. McGowan et al. ANNALS OF ONCOLOGY
- Macrophages define the invasive microenvironment in breast cancer
- (2008) Jeffrey W. Pollard JOURNAL OF LEUKOCYTE BIOLOGY
- The ADAM17–amphiregulin–EGFR Axis in Mammary Development and Cancer
- (2008) Mark D. Sternlicht et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Transforming Growth Factor Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab
- (2008) S. E. Wang et al. MOLECULAR AND CELLULAR BIOLOGY
- Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity
- (2008) M Scaltriti et al. ONCOGENE
- M-CSF Signals through the MAPK/ERK Pathway via Sp1 to Induce VEGF Production and Induces Angiogenesis In Vivo
- (2008) Jennifer M. Curry et al. PLoS One
- PI3K/PTEN signaling in tumorigenesis and angiogenesis
- (2007) Bing-Hua Jiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now